Injecting Wegovy in the Arm: What the Evidence Says

Where exactly on the arm, and why the trial evidence supports it

The STEP 1 trial, published in the New England Journal of Medicine, established semaglutide 2.4mg as effective for weight management across a large adult population, and throughout the trial, the upper arm was among the permitted injection sites alongside the abdomen and thigh. Absorption profiles across those sites are broadly equivalent, which is why all three are included in the licensed instructions for use.

The specific zone for an arm injection is the back of the upper arm, the outer, fatty area between the shoulder and the elbow. This is a subcutaneous site, meaning the needle goes into the layer of fat just under the skin, not into muscle. Injecting into muscle changes the absorption rate and can increase pain; subcutaneous delivery into the correct zone is what the product is designed for.

People who prefer the arm often do so because the abdomen becomes sore with frequent use, or because rotating properly across three sites reduces the risk of lipodystrophy, small but persistent changes to skin texture that can develop if the same spot is used repeatedly. Varying between upper arm injections and the other licensed sites is genuinely good practice, not just a convenience.

The practical reality of injecting Wegovy in the arm yourself

This is worth addressing directly: most people find it hard to inject the back of their own upper arm correctly. The geometry is awkward, and if you angle the pen wrongly you risk hitting muscle rather than subcutaneous fat, or choosing a spot closer to the elbow or shoulder than is ideal. That is not a failure of dexterity, it is just anatomy.

The usual recommendation is to ask a partner, family member or caregiver to give the injection when using the arm site. Some people manage with a mirror, but it takes practice. The Wegovy pen is designed to make the process straightforward once you are positioned: press firmly, listen for the click, hold for the count recommended in the patient information leaflet, and withdraw. Do not rub the site afterwards.

If your arm is consistently more uncomfortable than other sites, or you notice the area stays red longer than a day or two, it may be worth switching to the abdomen or thigh for a few weeks and reviewing with your prescriber. Persistent injection-site reactions are worth flagging. You can find more detail on what soreness after an arm injection typically means on the arm pain after Wegovy page.

One thing that surprises people: the pen can occasionally feel warm after sitting in your hand for a few minutes before injection. That is expected and is not a sign the medicine has been damaged, but if your pen has been left out of the fridge for longer than the window specified in the leaflet, it should not be used. Our guide on Wegovy temperature and storage explains exactly what to do.

Site rotation and what the licensed guidance says

The NHS semaglutide medicines page advises rotating injection sites each week, not just between arms, abdomen and thighs, but within each area. In the upper arm that means not using the identical square centimetre every time. A loose rota across the three areas, moving an inch or two within each, keeps skin tissue healthy over months and years of treatment.

The back of the upper arm (sometimes called the posterior aspect) is the recommended arm zone; the front or inner arm is not licensed and is more likely to be close to muscle or nerve pathways. If you are unsure which part of your arm you have been using, a quick look at the diagrams in your patient information leaflet will confirm the correct zone. That leaflet is the authoritative reference for your specific pen format, more reliable than any general description, including this one.

People transferring from one pen format to another, or moving up a dose, sometimes notice that injection-site comfort changes. The back-of-arm injection technique page covers positioning in more detail. For questions about the cost and service side of Wegovy treatment through a regulated UK pharmacy, the Wegovy cost page sets out what is typically included in a private prescription service.

When to flag an arm injection issue to your prescriber

Mild, short-lived redness or a small lump at the injection site is common and not a clinical concern. It usually reflects a normal skin response to the injection itself and settles within 48 hours. What warrants a conversation with your prescriber is anything that does not fit that pattern: swelling that grows rather than shrinks, pain that lasts more than two or three days, skin that looks infected (hot, spreading redness, pus), or any sign of an allergic reaction elsewhere on the body such as hives, difficulty breathing or facial swelling. The last of these is rare but requires immediate emergency attention.

Wegovy is a Black Triangle (▼) medicine, meaning the MHRA actively collects post-market safety data. If you experience a side effect that feels significant, you can report it directly at the MHRA Yellow Card scheme, patients can submit reports, not just clinicians. It is a genuinely useful system and takes only a few minutes.

If you are thinking about starting Wegovy or want to understand whether the arm site or another would suit you better given your circumstances, our prescribers review every consultation personally. Check your eligibility for a free clinical assessment.